Reply To: SGLT2

July 18, 2023 at 12:42 am #31424

Roshni John

Participant

Diabetes Education

Excellent drug but be cautious. Educate and monitor patient as SGLT2i significantly increase the risk of DKA in some patients with diabetes.

The Essentials